 |
|
Neuropathologic Outcome of Mild Cognitive Impairment Following Progression to Clinical Dementia
Gregory A. Jicha, MD, PhD;
Joseph E. Parisi, MD;
Dennis W. Dickson, MD;
Kris Johnson, RN;
Ruth Cha, MS;
Robert J. Ivnik, PhD;
Eric G. Tangalos, MD;
Bradley F. Boeve, MD;
David S. Knopman, MD;
Heiko Braak, MD;
Ronald C. Petersen, PhD, MD
Arch Neurol. 2006;63:674-681.
Background The pathologic outcome of patients diagnosed with mild cognitive impairment (MCI) following progression to dementia is poorly understood.
Objective To determine the pathologic substrates of dementia in cases with prior diagnosis of amnestic MCI.
Design and Setting Community-based cohort.
Patients Thirty-four subjects followed up prospectively as part of a community-based study who were diagnosed with amnestic MCI, progressed to clinical dementia, and underwent subsequent postmortem brain analysis.
Main Outcome Measures Neuropathologic analyses resulted in assignment of a primary pathologic diagnosis and included staging of Alzheimer pathologic abnormalities and identification of contributing vascular disease, Lewy bodies, and argyrophilic grains.
Results Although the majority of subjects progressed both clinically and pathologically to Alzheimer disease (AD), 10 (29%) of them developed non-AD primary pathologic abnormalities. All of the cases were found to have sufficient pathologic abnormalities in mesial temporal lobe structures to account for their amnestic symptoms regardless of the cause. Most subjects were found to have secondary contributing pathologic abnormalities in addition to primary pathologic diagnoses. No significant differences between subjects with and without neuropathologically proven AD were detected in demographic variables, apolipoprotein E genotype, or cognitive test measures at onset of MCI, onset of dementia, or last clinical evaluation.
Conclusions The neuropathologic outcome of amnestic MCI following progression to dementia is heterogeneous, and it includes AD at a high frequency. Complex neuropathologic findings including 2 or more distinct pathologic entities contributing to dementia may be common in community-based cohorts. Neither demographic variables nor cognitive measures had predictive value in determining which patients diagnosed with MCI will develop the neuropathologic features of AD.
Author Affiliations: Alzheimer's Disease Research Center (Drs Jicha, Parisi, Ivnik, Tangalos, Boeve, Knopman, and Petersen and Ms Johnson), Departments of Neurology (Drs Jicha, Boeve, Knopman, and Petersen), Laboratory Medicine and Pathology (Dr Parisi), Psychiatry and Psychology (Dr Ivnik), and Internal Medicine (Dr Tangalos), and Health Sciences Research (Ms Cha), Mayo Clinic, Rochester, Minn; Alzheimer's Disease Research Center and Department of Neurosciences, Mayo Clinic, Jacksonville, Fla (Dr Dickson); and Institute for Clinical Neuroanatomy, J. W. Goethe University, Frankfurt/Main, Germany (Dr Braak).
RELATED ARTICLE
The Neuropathology of Aging, Mild Cognitive Impairment, and Alzheimer Disease
Lawrence A. Hansen
Arch Neurol. 2006;63(5):647-648.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Mild Cognitive Impairment: Challenging Issues
Ganguli and Petersen
AJGP 2008;16:339-342.
FULL TEXT
MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment
Whitwell et al.
Neurology 2008;70:512-520.
ABSTRACT
| FULL TEXT
CIND AND MCI IN THE ITALIAN ELDERLY: FREQUENCY, VASCULAR RISK FACTORS, PROGRESSION TO DEMENTIA
Solfrizzi et al.
Neurology 2007;69:2186-2187.
FULL TEXT
Lobar Distribution of Changes in Gray Matter and White Matter in Memory Clinic Patients: Detected Using Magnetization Transfer Imaging
van Es et al.
Am. J. Neuroradiol. 2007;28:1938-1942.
ABSTRACT
| FULL TEXT
Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease
Boeve et al.
Brain 2007;130:2770-2788.
ABSTRACT
| FULL TEXT
Disease-modifying therapies for Alzheimer disease: Challenges to early intervention
Cummings et al.
Neurology 2007;69:1622-1634.
ABSTRACT
| FULL TEXT
Three-Dimensional Gray Matter Atrophy Mapping in Mild Cognitive Impairment and Mild Alzheimer Disease
Apostolova et al.
Arch Neurol 2007;64:1489-1495.
ABSTRACT
| FULL TEXT
3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease
Whitwell et al.
Brain 2007;130:1777-1786.
ABSTRACT
| FULL TEXT
Less Atherosclerosis and Lower Blood Pressure for a Meaningful Life Perspective With More Brain
Staessen et al.
Hypertension 2007;49:389-400.
FULL TEXT
Mild Cognitive Impairment Should Be Considered for DSM-V
Petersen and O'Brien
J Geriatr Psychiatry Neurol 2006;19:147-154.
ABSTRACT
Papers of Note
Sci Aging Knowl Environ 2006;2006:nw9-nw9.
FULL TEXT
The neuropathology of aging, mild cognitive impairment, and Alzheimer disease.
Hansen
Arch Neurol 2006;63:647-648.
FULL TEXT
|
